Silence Therapeutics (SLN) Other Non-Current Assets: 2023-2025
Historic Other Non-Current Assets for Silence Therapeutics (SLN) over the last 2 years, with Sep 2025 value amounting to $399,000.
- Silence Therapeutics' Other Non-Current Assets fell 85.68% to $399,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $399,000, marking a year-over-year decrease of 85.68%. This contributed to the annual value of $3.6 million for FY2024, which is 1.54% down from last year.
- Per Silence Therapeutics' latest filing, its Other Non-Current Assets stood at $399,000 for Q3 2025, which was down 89.80% from $3.9 million recorded in Q2 2025.
- In the past 5 years, Silence Therapeutics' Other Non-Current Assets registered a high of $3.9 million during Q2 2025, and its lowest value of $399,000 during Q3 2025.
- In the last 3 years, Silence Therapeutics' Other Non-Current Assets had a median value of $3.4 million in 2024 and averaged $3.0 million.
- Over the last 5 years, Silence Therapeutics' Other Non-Current Assets had its largest YoY gain of 31.30% in 2025, and its largest YoY loss of 85.68% in 2025.
- Silence Therapeutics' Other Non-Current Assets (Quarterly) stood at $3.6 million in 2023, then decreased by 1.54% to $3.6 million in 2024, then slumped by 85.68% to $399,000 in 2025.
- Its Other Non-Current Assets stands at $399,000 for Q3 2025, versus $3.9 million for Q2 2025 and $3.6 million for Q1 2025.